Weekly GLP-1 insights, community stories, and scientific updates — with podcast episodes.
Get weekly GLP-1 insights, community stories, and research delivered to your inbox.
Welcome to this week's Gila newsletter! We are exploring the latest science on GLP-1 health benefits, next-generation medications like Retatrutide, an...
Welcome to this week's Gila GLP-1 & Weight Loss newsletter! From FDA updates and breaking science on the anti-inflammatory power of GLP-1s, to communi...
Welcome to this week's Gila GLP-1 & Weight Loss newsletter. From the latest clinical insights on muscle preservation to heartfelt community success st...
Welcome to Gila GLP-1 & Weight Loss! This week, we’re exploring the science of how genetics influence GLP-1 results, exciting neuroprotective discover...
Welcome to Gila GLP-1 & Weight Loss! This week, we explore the fascinating science of meal timing, navigate emotional relationship shifts during weigh...
Welcome back to Gila. This week, we explore how our individual paths are driving monumental shifts—from FDA approvals for new oral GLP-1s and NHS expa...
Welcome to *Gila GLP-1 & Weight Loss*. This week, we curate insights on the future of GLP-1 accessibility, science-backed nutrition tips, mental healt...
Welcome to this week’s Gila GLP-1 & Weight Loss newsletter. Navigating a GLP-1 journey is profoundly transformative, bridging metabolic science with e...
Welcome back to Gila! This week, we are looking beyond the scale to explore the science of body recomposition, the exciting potential of GLP-1s in man...
Welcome back to Gila! This week, we explore potential cost breakthroughs for semaglutide and the vital differences between Zepbound and Mounjaro. We a...
Welcome back to Gila. This week, we bridge the gap between complex biology and daily behavior. From groundbreaking research on how our cells "remember...
Welcome back, Gila community. This week feels like a pivotal moment—from Serena Williams sharing her truth to McDonald’s testing high-protein options,...
Welcome to this week’s edition, where we celebrate the "whole" you. From groundbreaking research on cancer risks and heart health to finally saying go...
Welcome to this week's Gila GLP-1 & Weight Loss newsletter! We're so glad you're here on your transformative journey. This week, we delve into excitin...
Welcome to Gila GLP-1 & Weight Loss—this week we scan rising oral options, a new contender with promising weight-loss data, and early research on brai...
Hello and welcome to this week's edition of Gila GLP-1 & Weight Loss! We’re excited to share a wealth of curated content designed to support...
Hello and welcome to this week's newsletter from Gila GLP-1 & Weight Loss! We're excited to support you on your journey with GLP-1 medicatio...
Welcome to Gila GLP-1 & Weight Loss. This week: Wegovy pill access evolves; hydration hacks that ease side effects; supplement safety; willp...
Welcome to Gila GLP‑1 & Weight Loss—your weekly, science‑led roundup of what matters. This week: access is evolving (CMS’s BALANCE demo), th...
Welcome to Gila GLP-1 & Weight Loss. This week’s curated highlights span safety and access (UK warning on social-media jabs; FDA’s oral Wego...